Prabhjot Singh, MD, PhD, Director, Mount Sinai’s Arnhold Institute for Global Health, Named 2017 Presidential Leadership Scholar
The Presidential Leadership Scholars program, a unique leadership development initiative that draws upon the resources of the presidential centers of George W. Bush, William J. Clinton, George H.W. Bush, and Lyndon B. Johnson, this week announced that Prabhjot Singh, MD, PhD, has been selected to participate. Dr. Singh, Director of The Arnhold Institute for Global Health and Chair, Department of Health System Design, Icahn School of Medicine at Mount Sinai, is one of 60 Scholars chosen for the program’s third annual class.
“Dr. Singh has demonstrated the kind of leadership required to tackle the complexity of issues facing the health care industry today,” said Kenneth L. Davis, President and Chief Executive Officer, Mount Sinai Health System. “At Mount Sinai, Dr. Singh’s work has demonstrated how global health systems and programs successfully deployed abroad can be adapted and scaled to transform the way health care is delivered domestically. His work has also been crucial in helping steer our health system away from fee-for-service medicine to population health management. We are proud to have Dr. Singh represent the Mount Sinai Health System as a Presidential Leadership Scholar, and I look forward to his ongoing contributions and career successes.”
The third cohort was selected after a rigorous application and review process. Scholars were selected based on their leadership growth potential and the strength of their personal leadership projects aimed at improving the civic or social good by addressing a problem or need in a community, profession, or organization.
“I’m honored and humbled to have been selected for this year’s Presidential Leadership Scholars Program,” Dr. Singh said. “I look forward to leveraging insights gained from my peers in the program, as well as from the resources of four presidents, to further my goal of breaking down barriers between U.S. health systems and the world around us.”
Dr. Singh was recruited to the Icahn School of Medicine in 2015 from Columbia University, where he was Director of Systems Design at the Earth Institute and a faculty member in International and Public Affairs. He has a PhD in neural and genetic systems from The Rockefeller University and a medical degree from Weill Cornell Medical College, and completed fellowship training in sustainable development at Columbia University, and an internal medicine residency at Mount Sinai.
Over the course of several months, Scholars will travel to each participating presidential center to learn from former presidents, key administration officials, and leading academics. They will study and put into practice varying approaches to leadership, develop a network of peers, and exchange ideas with mentors and others who can help them make an impact in their communities.
The program kicks off in Washington, D.C., on February 7, where Scholars will visit the National Archives and Records Administration, Mount Vernon, and the White House Historical Association and explore personal and professional development areas including core values and civility.
The latest class joins the alumni network of 121 Scholars in the program. They include individuals from diverse backgrounds and geographies, coming from a variety of sectors, including private, public, non-profit, military, and academia.
To learn more about the Presidential Leadership Scholars program, visit www.presidentialleadershipscholars.org. For updates about the Presidential Leadership Scholars, use #PresidentialScholars or follow @PLSprogram on Twitter and Medium.
About the Arnhold Institute for Global Health
The Arnhold Institute for Global Health at the Icahn School of Medicine, Mount Sinai Health System, seeks to improve the health of people and the communities they live in, both in the United States and abroad. The Arnhold Institute serves as a global arm of the Mount Sinai Health System, leading research on the design of more equitable and effective care models that are disseminated through digital products, training systems and input on policy design.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, an integrated health care system which includes seven hospitals and an expanding ambulatory network serving approximately 4 million patients per year.
The School has more than 1,800 students in MD, PhD, and Master’s programs and post-doctoral fellowships; more than 5,600 faculty members; over 2,000 residents and fellows; and 23 clinical and research institutes and 34 academic departments. It is ranked among the highest in the nation in National Institutes of Health funding per principal investigator. The School was the first medical school in the country to create a progressive admissions approach for students who seek early assurance of admission through the FlexMed program.
The Graduate School of Biomedical Science trains PhD and MD/PhD students, and offers master’s-level programs in areas such as genetic counseling, clinical research, biomedical sciences, and public health, and an online master’s degree in health care delivery leadership. The seamless connections between our medical school, graduate school, and hospital campuses provide an extraordinary environment for translating scientific discoveries into clinical treatments.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.